ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison

被引：18
|
作者：
Myllynen, Paivi [1 ]
Kummu, Maria [1 ,2 ]
Sieppi, Elina [1 ]
机构：
[1] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland
[2] Univ Oulu, Ctr Arctic Med, Thule Inst, FIN-90014 Oulu, Finland
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2010年 / 6卷 / 11期
关键词：
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; LIMITS FETAL DISTRIBUTION; MULTIDRUG-RESISTANCE; PHOSPHOGLYCOPROTEIN ABCB1; DRUG TRANSPORTERS; GENE-EXPRESSION; MOUSE PLACENTA; RAT PLACENTA; BCRP/ABCG2;
D O I：
10.1517/17425255.2010.514264
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Areas covered in this review: Comprehensive literature searches were done using PubMed (until June 2010) to identify publications on ABCB1 and ABCG2 expression in placenta and fetal tissues in human, mouse, rat, guinea-pig and rabbit. What the reader will gain: In this review, we aim to provide an overview of the current knowledge on the ABCB1 and ABCG2 transporter expression profiles in the placenta and fetal tissues in humans relative to other species. Take home message: The available information on ABCB1 and ABCG2 temporal expression profiles in placenta and fetus indicates rather good correlation among human, mouse and rat although some specific differences have been reported. However, at this point no detailed comparisons or comparative functional data are available. Detailed knowledge on the expression patterns and functional activity of ABCB1 and ABCG2 transporters placenta and developing embryo/fetus in different species could possibly help the interspecies extrapolation.
引用
收藏
页码：1385 / 1398
页数：14
相关论文
共 50 条
  • [21] Expression of the ABC transport proteins MDR1 (ABCB1) and BCRP (ABCG2) in bovine rumen
    I. S. Haslam
    N. L. Simmons
    Journal of Comparative Physiology B, 2014, 184 : 673 - 681
  • [22] Inhibition of ABCB1 and ABCG2 at the Mouse Blood Brain-Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [11C]erlotinib
    Traxl, Alexander
    Mairinger, Severin
    Filip, Thomas
    Sauberer, Michael
    Stanek, Johann
    Poschner, Stefan
    Jaeger, Walter
    Zoufal, Viktoria
    Novarino, Gaia
    Tournier, Nicolas
    Bauer, Martin
    Wanek, Thomas
    Langer, Oliver
    MOLECULAR PHARMACEUTICS, 2019, 16 (03) : 1282 - 1293
  • [23] The Pim Kinase Inhibitor SGI-1776 Chemosensitizes Multidrug Resistant Cells by Both Inhibiting Drug Transport by ABCB1 and ABCG2 and Decreasing ABCB1 and ABCG2 Surface Expression On Cells That Overexpress Pim-1
    Natarajan, Karthika
    Bhullar, Jasjeet
    Shukla, Suneet
    Burcu, Mehmet
    Ambudkar, Suresh V.
    Baer, Maria R.
    BLOOD, 2012, 120 (21)
  • [24] Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists
    Silbermann, Katja
    Li, Jiyang
    Namasivayam, Vigneshwaran
    Baltes, Fabian
    Bendas, Gerd
    Stefan, Sven Marcel
    Wiese, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (18) : 10412 - 10432
  • [25] ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
    El Biali, Myriam
    Karch, Rudolf
    Philippe, Cecile
    Haslacher, Helmuth
    Tournier, Nicolas
    Hacker, Marcus
    Zeitlinger, Markus
    Schmidl, Doreen
    Langer, Oliver
    Bauer, Martin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [26] Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo
    Lin, Fan
    Hoogendijk, Lisette
    Buil, Levi
    Beijnen, Jos H.
    van Tellingen, Olaf
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 2059 - 2064
  • [27] Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans
    Kim, Kyoung-Ah
    Cha, Yu-Jung
    Lee, Hae-Mi
    Joo, Hyun-Jin
    Park, Ji-Young
    CLINICA CHIMICA ACTA, 2015, 438 : 7 - 11
  • [28] Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
    de Gooijer, Mark C.
    de Vries, Nienke A.
    Buckle, Tessa
    Buil, Levi C. M.
    Beijnen, Jos H.
    Boogerd, Willem
    van Tellingen, Olaf
    NEOPLASIA, 2018, 20 (07): : 710 - 720
  • [29] Measurement of hepatic abcb1 and abcg2 transport activity with positron emission tomography
    Lozano, I. Hernandez
    Wulkersdorfer, B.
    Traxl, A.
    Bauer, M.
    Philippe, C.
    Stieger, B.
    Ozvegy-Laczka, C.
    Szakacs, G.
    Wanek, T.
    Hacker, M.
    Zeitlinger, M.
    Langer, O.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S41 - S41
  • [30] Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance
    Nimisha, Sundeep Singh
    Saluja, Sundeep Singh
    Sharma, Abhay Kumar
    Nekarakanti, Phani Kumar
    Apurva, Real Sumayya Abdul
    Kumar, Arun
    Sattar, Real Sumayya Abdul
    Anjum, Hasib
    Batra, Vineeta Vijay
    Husain, Syed Akhtar
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (10) : 2379 - 2394
12345